SC TO SC TO-I EX-FILING FEES 0001634452 AB Private Credit Investors Corp 0-11 Y SC TO Y SC TO Y SC TO N SC TO N SC TO N SC TO 0001634452 2025-08-29 2025-08-29 0001634452 1 2025-08-29 2025-08-29 0001634452 1 2025-08-29 2025-08-29 0001634452 2 2025-08-29 2025-08-29 0001634452 3 2025-08-29 2025-08-29 0001634452 4 2025-08-29 2025-08-29 0001634452 5 2025-08-29 2025-08-29 0001634452 6 2025-08-29 2025-08-29 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

Table 1: Transaction Valuation

Transaction Valuation

Fee Rate

Amount of Filing Fee

Fees to be Paid 1 $ 16,258,347.24 0.0001531 $ 2,489.15
Fees Previously Paid

Total Transaction Valuation:

$ 16,258,347.24

Total Fees Due for Filing:

$ 2,489.15

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 2,489.15

Net Fee Due:

$ 0.00

Offering Note

1

(1) Calculated solely for purposes of determining the amount of the filing fee. This amount is based upon the offer to purchase up to 1,713,208.35 shares of common stock, par value $0.01 per share, of AB Private Credit Investors Corporation, at a price equal to $9.49 per share, which represents the Fund's net asset value per share as of June 30, 2025, and is used for purposes of calculating the estimated aggregate maximum purchase price for shares. (2) The amount of the filing fee, calculated in accordance with Rule 0-11 under the Securities Exchange Act of 1934, as amended, as modified by Fee Rate Advisory No. 1 for fiscal year 2025, equals $153.10 per million dollars of the value of the transaction.
Table 2: Fee Offset Claims and Sources ☐Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Fee Paid with Fee Offset Source
Fee Offset Claims 1, 2 Schedule TO 005-90731 02/26/2021 $ 648.41
Fee Offset Claims 3 Schedule TO 005-90731 08/16/2019 $ 1,518.72
Fee Offset Claims 4 Schedule TO 005-90731 05/17/2019 $ 322.02
Fee Offset Sources AB Private Credit Investors Corp Schedule TO 005-90731 03/31/2021 $ 648.41
Fee Offset Sources AB Private Credit Investors Corp Schedule TO 005-90731 08/16/2019 $ 1,518.72
Fee Offset Sources AB Private Credit Investors Corp Schedule TO 005-90731 05/17/2019 $ 322.02

Explanation of the basis for claimed offset:

1

An aggregate fee of $2,125.52 was paid with the filing of the Schedule TO-I by the Company (File No. 005-90731) on February 26, 2021 (the "February 2021 Schedule TO-I"). The final transaction fee due pursuant to the final amendment to the February 2021 Schedule TO-I filed on May 10, 2021 was $1,206.85, as $11,061,880.89 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $2,125.52 filing fee paid in connection with the February 2021 Schedule TO-I was used to offset the filing fee due in connection with the filing of the May 2025 Schedule TO-I. More specifically, $270.26 from the filing fee paid in connection with the February 2021 Schedule TO-I was used to offset the final transaction fee due from the filing of the May 2025 Schedule TO-I. A portion of the remaining $1,528.95 filing fee paid in connection with the February 2021 Schedule TO-I is being used to offset a portion of the filing fee in connection with this Schedule TO-I.

3

An aggregate fee of $1,528.95 was paid with the filing of the Schedule TO-I by the Company (File No. 005-90731) on August 16, 2019 (the "August 2019 Schedule TO-I"). The final transaction fee due pursuant to the final amendment to the August 2019 Schedule TO-I filed on September 30, 2019 was $10.23, as $84,413.35 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $1,528.95 filing fee paid in connection with the August 2019 Schedule TO-I is being used to offset a portion of the filing fee in connection with this Schedule TO-I.

4

An aggregate fee of $1,532.03 was paid with the filing of the Schedule TO-I by the Company (File No. 005-90731) on May 17, 2019 (the "May 2019 Schedule TO-I"). The final transaction fee due pursuant to the final amendment to the May 2019 Schedule TO-I filed on June 26, 2019 was $9.10, as $75,042.34 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $1,532.03 filing fee paid in connection with the May 2019 Schedule TO-I is being used to offset a portion of the filing fee in connection with this Schedule TO-I.

Offset Note

2

(3) An aggregate fee of $941.37 was paid with the filing of the Schedule TO-I by the Company (File No. 005-90731) on August 26, 2022 (the "August 2022 Schedule TO-I"). The final transaction fee due pursuant to the final amendment to the August 2022 Schedule TO-I filed on November 14, 2022 was $329.58, as $3,555,388.97 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $941.37 filing fee paid in connection with the August 2022 Schedule TO-I was used to offset the filing fee due in connection with the filing of the Schedule TO-I by the Company (File No. 005-90731) on February 28, 2025 (the "February 2025 Schedule TO-I") and the filing of the Schedule TO-I by the Company (File No. 005-90731) on May 23, 2025 (the "May 2025 Schedule TO-I"). More specifically, $589.61 from the filing fee paid in connection with the August 2022 Schedule TO-I was used to offset the final transaction fee due from the filing of the February 2025 Schedule TO-I, and $32.18 was used to offset the final transaction fee due from the filing of the May 2025 Schedule TO-I. An aggregate fee of $819.09 was paid with the filing of the Schedule TO-I by the Company (File No. 005-90731) on May 27, 2022 (the "May 2022 Schedule TO-I"). The final transaction fee due pursuant to the final amendment to the May 2022 Schedule TO-I filed on August 12, 2022 was $555.34, as $5,990,764.58 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $819.09 filing fee paid in connection with the May 2022 Schedule TO-I was used to offset the filing fee due in connection with the filing of the May 2025 Schedule TO-I. More specifically, $263.75 from the filing fee paid in connection with the May 2022 Schedule TO-I was used to offset the final transaction fee due from the filing of the May 2025 Schedule TO-I. An aggregate fee of $721.64 was paid with the filing of the Schedule TO-I by the Company (File No. 005-90731) on February 25, 2022 (the "February 2022 Schedule TO-I"). The final transaction fee due pursuant to the final amendment to the February 2022 Schedule TO-I filed on May 13, 2022 was $378.34, as $4,081,369.77 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $721.64 filing fee paid in connection with the February 2022 Schedule TO-I was used to offset the filing fee due in connection with the filing of the May 2025 Schedule TO-I. More specifically, $343.30 from the filing fee paid in connection with the February 2022 Schedule TO-I was used to offset the final transaction fee due from the filing of the May 2025 Schedule TO-I. An aggregate fee of $635.45 was paid with the filing of the Schedule TO-I by the Company (File No. 005-90731) on November 26, 2021 (the "November 2021 Schedule TO-I"). The final transaction fee due pursuant to the final amendment to the November 2021 Schedule TO-I filed on February 16, 2022 was $439.04, as $4,736,138.63 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $635.45 filing fee paid in connection with the November 2021 Schedule TO-I was used to offset the filing fee due in connection with the filing of the May 2025 Schedule TO-I. More specifically, $196.41 from the filing fee paid in connection with the November 2021 Schedule TO-I was used to offset the final transaction fee due from the filing of the May 2025 Schedule TO-I. An aggregate fee of $1,359.69 was paid with the filing of the Schedule TO-I by the Company (File No. 005-90731) on May 28, 2021 (the "May 2021 Schedule TO-I"). The final transaction fee due pursuant to the final amendment to the May 2021 Schedule TO-I filed on August 5, 2021 was $1,224.15, as $11,220,395.48 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $1,359.69 filing fee paid in connection with the May 2021 Schedule TO-I was used to offset the filing fee due in connection with the filing of the May 2025 Schedule TO-I. More specifically, $135.54 from the filing fee paid in connection with the May 2021 Schedule TO-I was used to offset the final transaction fee due from the filing of the May 2025 Schedule TO-I. An aggregate fee of $2,125.52 was paid with the filing of the Schedule TO-I by the Company (File No. 005-90731) on February 26, 2021 (the "February 2021 Schedule TO-I"). The final transaction fee due pursuant to the final amendment to the February 2021 Schedule TO-I filed on May 10, 2021 was $1,206.85, as $11,061,880.89 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $2,125.52 filing fee paid in connection with the February 2021 Schedule TO-I was used to offset the filing fee due in connection with the filing of the May 2025 Schedule TO-I. More specifically, $270.26 from the filing fee paid in connection with the February 2021 Schedule TO-I was used to offset the final transaction fee due from the filing of the May 2025 Schedule TO-I. A portion of the remaining $1,528.95 filing fee paid in connection with the February 2021 Schedule TO-I is being used to offset a portion of the filing fee in connection with this Schedule TO-I. An aggregate fee of $1,528.95 was paid with the filing of the Schedule TO-I by the Company (File No. 005-90731) on August 16, 2019 (the "August 2019 Schedule TO-I"). The final transaction fee due pursuant to the final amendment to the August 2019 Schedule TO-I filed on September 30, 2019 was $10.23, as $84,413.35 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $1,528.95 filing fee paid in connection with the August 2019 Schedule TO-I is being used to offset a portion of the filing fee in connection with this Schedule TO-I. An aggregate fee of $1,532.03 was paid with the filing of the Schedule TO-I by the Company (File No. 005-90731) on May 17, 2019 (the "May 2019 Schedule TO-I"). The final transaction fee due pursuant to the final amendment to the May 2019 Schedule TO-I filed on June 26, 2019 was $9.10, as $75,042.34 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $1,532.03 filing fee paid in connection with the May 2019 Schedule TO-I is being used to offset a portion of the filing fee in connection with this Schedule TO-I.